Genzyme, a Sanofi company, has entered a research collaboration with Cleveland Clinic to develop new therapeutic approaches to treat MS. The collaboration will align the research efforts of both organizations around projects designed to address the unmet medical needs in MS, particularly progressive forms of the disease.   The collaboration will initially focus on projects to address neurodegeneration and novel technologies to better understand the pathology of the disease. The collaboration wil...